Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xi,Jia

第一单位： Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

作者： Xi,Jia ^[1] ; Naying,Liao ^[2] ; Sijian,Yu ^[1] ; Huan,Li ^[2] ; Hui,Liu ^[1] ; Haiyan,Zhang ^[2] ; Jun,Xu ^[1] ; Yunqian,Yao ^[2] ; Han,He ^[1] ; Guopan,Yu ^[2] ; Qifa,Liu ^[1] ; Yu,Zhang ^[2] ; Pengcheng,Shi ^[1]

作者单位： Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[1] Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China. ^[2]

关键词 CD19 MRD allogeneic stem cell transplantation chemotherapy t(8;21) AML

主题词成年人(Adult);人类(Humans);移植, 同种(Transplantation, Homologous);造血干细胞移植(Hematopoietic Stem Cell Transplantation);干细胞移植(Stem Cell Transplantation);复发(Recurrence);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);肿瘤, 残余(Neoplasm, Residual);回顾性研究(Retrospective Studies);预后(Prognosis)

DOI 10.1002/cam4.7074

PMID 38457215

发布时间 2024-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2024年13卷4期

e7074页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除